Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-08-01 Sale | 2024-08-05 6:39 pm | REGENXBIO Inc. | RGNX | Simpson Curran Chief Executive Officer | 100 | $15 | $1,500 | 170,037 (Direct) | View |
2024-07-29 Sale | 2024-07-30 5:01 pm | REGENXBIO Inc. | RGNX | Simpson Curran Chief Executive Officer | 9,648 | $15.04 | $145,106 | 170,137 (Direct) | View |
2021-01-12 Sale | 2021-01-14 6:55 pm | REGENXBIO Inc. | RGNX | Simpson Curran Chief Oper. & Tech. Officer | 13,312 | $50.01 | $665,767 | 36,116 (Direct) | View |
2021-01-07 Sale | 2021-01-11 4:29 pm | REGENXBIO Inc. | RGNX | Simpson Curran Chief Oper. & Tech. Officer | 5,185 | $50.01 | $259,302 | 20,688 (Direct) | View |
2020-02-10 Sale | 2020-02-12 4:27 pm | REGENXBIO Inc. | RGNX | Simpson Curran SVP, Product Development & CTO | 56,993 | $50.28 | $2,865,636 | 46,206 (Direct) | View |
2020-02-05 Sale | 2020-02-07 4:23 pm | REGENXBIO Inc. | RGNX | Simpson Curran SVP, Product Development & CTO | 5,637 | $50 | $281,850 | 96,566 (Direct) | View |
2020-01-17 Sale | 2020-01-21 4:18 pm | REGENXBIO Inc. | RGNX | Simpson Curran SVP, Product Development & CTO | 5,922 | $50 | $296,100 | 99,495 (Direct) | View |
2019-12-09 Sale | 2019-12-11 4:24 pm | REGENXBIO Inc. | RGNX | Simpson Curran SVP, Product Development & CTO | 15,552 | $43.74 | $680,248 | 23,948 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-07-01 Option Award | 2024-07-03 07:56 am | N/A 2034-07-01 | REGENXBIO Inc. | RGNX | Simpson Curran Chief Executive Officer | 328,647 | $0 | 451,974 (Direct) | View |
2024-01-02 Tax Withholding | 2024-01-04 4:34 pm | N/A N/A | REGENXBIO Inc. | RGNX | Simpson Curran Chief Oper. & Tech. Officer | 8,120 | $17.95 | 184,377 (Direct) | View |
2024-01-02 Option Award | 2024-01-04 4:34 pm | N/A 2034-01-02 | REGENXBIO Inc. | RGNX | Simpson Curran Chief Oper. & Tech. Officer | 99,512 | $0 | 184,377 (Direct) | View |
2023-01-03 Tax Withholding | 2023-01-05 4:06 pm | N/A N/A | REGENXBIO Inc. | RGNX | Simpson Curran Chief Oper. & Tech. Officer | 2,076 | $22.68 | 145,971 (Direct) | View |
2023-01-03 Option Award | 2023-01-05 4:06 pm | N/A 2033-01-03 | REGENXBIO Inc. | RGNX | Simpson Curran Chief Oper. & Tech. Officer | 120,931 | $0 | 145,971 (Direct) | View |
2022-01-01 Tax Withholding | 2022-01-04 9:06 pm | N/A N/A | REGENXBIO Inc. | RGNX | Simpson Curran Chief Oper. & Tech. Officer | 1,332 | $32.7 | 78,216 (Direct) | View |
2022-01-03 Option Award | 2022-01-04 9:06 pm | N/A 2032-01-03 | REGENXBIO Inc. | RGNX | Simpson Curran Chief Oper. & Tech. Officer | 61,800 | $0 | 78,216 (Direct) | View |
2021-01-12 Exercise | 2021-01-14 6:55 pm | N/A 2027-01-03 | REGENXBIO Inc. | RGNX | Simpson Curran Chief Oper. & Tech. Officer | 13,312 | $0 | 36,116 (Direct) | View |
2021-01-12 Exercise | 2021-01-14 6:55 pm | N/A N/A | REGENXBIO Inc. | RGNX | Simpson Curran Chief Oper. & Tech. Officer | 2,940 | $19.5 | 36,116 (Direct) | View |
2021-01-14 Exercise | 2021-01-14 6:55 pm | N/A N/A | REGENXBIO Inc. | RGNX | Simpson Curran Chief Oper. & Tech. Officer | 10,372 | $35.8 | 36,116 (Direct) | View |
2021-01-07 Exercise | 2021-01-11 4:29 pm | N/A 2027-01-03 | REGENXBIO Inc. | RGNX | Simpson Curran Chief Oper. & Tech. Officer | 5,185 | $0 | 20,688 (Direct) | View |
2021-01-07 Exercise | 2021-01-11 4:29 pm | N/A N/A | REGENXBIO Inc. | RGNX | Simpson Curran Chief Oper. & Tech. Officer | 5,185 | $19.5 | 20,688 (Direct) | View |
2021-01-04 Option Award | 2021-01-06 08:55 am | N/A 2031-01-04 | REGENXBIO Inc. | RGNX | Simpson Curran Chief Oper. & Tech. Officer | 76,100 | $0 | 80,048 (Direct) | View |
2020-02-10 Exercise | 2020-02-12 4:27 pm | N/A 2028-01-03 | REGENXBIO Inc. | RGNX | Simpson Curran SVP, Product Development & CTO | 38,293 | $0 | 46,206 (Direct) | View |
2020-02-10 Exercise | 2020-02-12 4:27 pm | N/A N/A | REGENXBIO Inc. | RGNX | Simpson Curran SVP, Product Development & CTO | 4,253 | $19.5 | 46,206 (Direct) | View |
2020-02-10 Exercise | 2020-02-12 4:27 pm | N/A N/A | REGENXBIO Inc. | RGNX | Simpson Curran SVP, Product Development & CTO | 21,561 | $22 | 46,206 (Direct) | View |
2020-02-10 Exercise | 2020-02-12 4:27 pm | N/A N/A | REGENXBIO Inc. | RGNX | Simpson Curran SVP, Product Development & CTO | 12,479 | $35.8 | 46,206 (Direct) | View |
2020-02-05 Exercise | 2020-02-07 4:23 pm | N/A 2028-01-03 | REGENXBIO Inc. | RGNX | Simpson Curran SVP, Product Development & CTO | 5,137 | $0 | 96,566 (Direct) | View |
2020-02-05 Exercise | 2020-02-07 4:23 pm | N/A N/A | REGENXBIO Inc. | RGNX | Simpson Curran SVP, Product Development & CTO | 1,000 | $19.5 | 96,566 (Direct) | View |
2020-02-05 Exercise | 2020-02-07 4:23 pm | N/A N/A | REGENXBIO Inc. | RGNX | Simpson Curran SVP, Product Development & CTO | 2,708 | $13.09 | 96,566 (Direct) | View |
2020-02-05 Exercise | 2020-02-07 4:23 pm | N/A N/A | REGENXBIO Inc. | RGNX | Simpson Curran SVP, Product Development & CTO | 958 | $22 | 96,566 (Direct) | View |
2020-02-05 Exercise | 2020-02-07 4:23 pm | N/A N/A | REGENXBIO Inc. | RGNX | Simpson Curran SVP, Product Development & CTO | 471 | $35.8 | 96,566 (Direct) | View |
2020-01-17 Exercise | 2020-01-21 4:18 pm | N/A 2028-01-03 | REGENXBIO Inc. | RGNX | Simpson Curran SVP, Product Development & CTO | 5,122 | $0 | 99,495 (Direct) | View |
2020-01-17 Exercise | 2020-01-21 4:18 pm | N/A N/A | REGENXBIO Inc. | RGNX | Simpson Curran SVP, Product Development & CTO | 1,622 | $19.5 | 99,495 (Direct) | View |
2020-01-17 Exercise | 2020-01-21 4:18 pm | N/A N/A | REGENXBIO Inc. | RGNX | Simpson Curran SVP, Product Development & CTO | 2,700 | $22 | 99,495 (Direct) | View |
2020-01-17 Exercise | 2020-01-21 4:18 pm | N/A N/A | REGENXBIO Inc. | RGNX | Simpson Curran SVP, Product Development & CTO | 800 | $35.8 | 99,495 (Direct) | View |
2020-01-02 Option Award | 2020-01-06 4:24 pm | N/A 2030-01-02 | REGENXBIO Inc. | RGNX | Simpson Curran SVP, Product Development & CTO | 46,000 | $0 | 46,000 (Direct) | View |